Pruritus Therapeutics Industry Research Report 2024
Summary
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, The global Pruritus Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.
The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, The global Pruritus Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.
The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- J&J
- Abbott
- Amgen
- LEO Pharma
- Novartis
- Bayer
- Pfizer
- UCB Pharma
- GlaxoSmithKline
- Galderma
- Huapont
- Antihistamines
- Corticosteroids
- Calcineurin Inhibitors
- Others
- External Use
- Oral
- Injection
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Pruritus Therapeutics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Antihistamines
2.2.3 Corticosteroids
2.2.4 Calcineurin Inhibitors
2.2.5 Others
2.3 Pruritus Therapeutics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 External Use
2.3.3 Oral
2.3.4 Injection
2.4 Assumptions and Limitations
3 PRURITUS THERAPEUTICS BREAKDOWN DATA BY TYPE
3.1 Global Pruritus Therapeutics Historic Market Size by Type (2019-2024)
3.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2025-2030)
4 PRURITUS THERAPEUTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Pruritus Therapeutics Historic Market Size by Application (2019-2024)
4.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Pruritus Therapeutics Market Perspective (2019-2030)
5.2 Global Pruritus Therapeutics Growth Trends by Region
5.2.1 Global Pruritus Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Pruritus Therapeutics Historic Market Size by Region (2019-2024)
5.2.3 Pruritus Therapeutics Forecasted Market Size by Region (2025-2030)
5.3 Pruritus Therapeutics Market Dynamics
5.3.1 Pruritus Therapeutics Industry Trends
5.3.2 Pruritus Therapeutics Market Drivers
5.3.3 Pruritus Therapeutics Market Challenges
5.3.4 Pruritus Therapeutics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Pruritus Therapeutics Players by Revenue
6.1.1 Global Top Pruritus Therapeutics Players by Revenue (2019-2024)
6.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
6.2 Global Pruritus Therapeutics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Pruritus Therapeutics Head office and Area Served
6.4 Global Pruritus Therapeutics Players, Product Type & Application
6.5 Global Pruritus Therapeutics Players, Date of Enter into This Industry
6.6 Global Pruritus Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Pruritus Therapeutics Market Size (2019-2030)
7.2 North America Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Pruritus Therapeutics Market Size by Country (2019-2024)
7.4 North America Pruritus Therapeutics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Pruritus Therapeutics Market Size (2019-2030)
8.2 Europe Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Pruritus Therapeutics Market Size by Country (2019-2024)
8.4 Europe Pruritus Therapeutics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Pruritus Therapeutics Market Size (2019-2030)
9.2 Asia-Pacific Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Pruritus Therapeutics Market Size by Country (2019-2024)
9.4 Asia-Pacific Pruritus Therapeutics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Pruritus Therapeutics Market Size (2019-2030)
10.2 Latin America Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Pruritus Therapeutics Market Size by Country (2019-2024)
10.4 Latin America Pruritus Therapeutics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pruritus Therapeutics Market Size (2019-2030)
11.2 Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Pruritus Therapeutics Market Size by Country (2019-2024)
11.4 Middle East & Africa Pruritus Therapeutics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 J&J
12.1.1 J&J Company Information
12.1.2 J&J Business Overview
12.1.3 J&J Revenue in Pruritus Therapeutics Business (2019-2024)
12.1.4 J&J Pruritus Therapeutics Product Portfolio
12.1.5 J&J Recent Developments
12.2 Abbott
12.2.1 Abbott Company Information
12.2.2 Abbott Business Overview
12.2.3 Abbott Revenue in Pruritus Therapeutics Business (2019-2024)
12.2.4 Abbott Pruritus Therapeutics Product Portfolio
12.2.5 Abbott Recent Developments
12.3 Amgen
12.3.1 Amgen Company Information
12.3.2 Amgen Business Overview
12.3.3 Amgen Revenue in Pruritus Therapeutics Business (2019-2024)
12.3.4 Amgen Pruritus Therapeutics Product Portfolio
12.3.5 Amgen Recent Developments
12.4 LEO Pharma
12.4.1 LEO Pharma Company Information
12.4.2 LEO Pharma Business Overview
12.4.3 LEO Pharma Revenue in Pruritus Therapeutics Business (2019-2024)
12.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
12.4.5 LEO Pharma Recent Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Revenue in Pruritus Therapeutics Business (2019-2024)
12.5.4 Novartis Pruritus Therapeutics Product Portfolio
12.5.5 Novartis Recent Developments
12.6 Bayer
12.6.1 Bayer Company Information
12.6.2 Bayer Business Overview
12.6.3 Bayer Revenue in Pruritus Therapeutics Business (2019-2024)
12.6.4 Bayer Pruritus Therapeutics Product Portfolio
12.6.5 Bayer Recent Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Revenue in Pruritus Therapeutics Business (2019-2024)
12.7.4 Pfizer Pruritus Therapeutics Product Portfolio
12.7.5 Pfizer Recent Developments
12.8 UCB Pharma
12.8.1 UCB Pharma Company Information
12.8.2 UCB Pharma Business Overview
12.8.3 UCB Pharma Revenue in Pruritus Therapeutics Business (2019-2024)
12.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
12.8.5 UCB Pharma Recent Developments
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Information
12.9.2 GlaxoSmithKline Business Overview
12.9.3 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2019-2024)
12.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
12.9.5 GlaxoSmithKline Recent Developments
12.10 Galderma
12.10.1 Galderma Company Information
12.10.2 Galderma Business Overview
12.10.3 Galderma Revenue in Pruritus Therapeutics Business (2019-2024)
12.10.4 Galderma Pruritus Therapeutics Product Portfolio
12.10.5 Galderma Recent Developments
12.11 Huapont
12.11.1 Huapont Company Information
12.11.2 Huapont Business Overview
12.11.3 Huapont Revenue in Pruritus Therapeutics Business (2019-2024)
12.11.4 Huapont Pruritus Therapeutics Product Portfolio
12.11.5 Huapont Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Pruritus Therapeutics by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Antihistamines
2.2.3 Corticosteroids
2.2.4 Calcineurin Inhibitors
2.2.5 Others
2.3 Pruritus Therapeutics by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 External Use
2.3.3 Oral
2.3.4 Injection
2.4 Assumptions and Limitations
3 PRURITUS THERAPEUTICS BREAKDOWN DATA BY TYPE
3.1 Global Pruritus Therapeutics Historic Market Size by Type (2019-2024)
3.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2025-2030)
4 PRURITUS THERAPEUTICS BREAKDOWN DATA BY APPLICATION
4.1 Global Pruritus Therapeutics Historic Market Size by Application (2019-2024)
4.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Pruritus Therapeutics Market Perspective (2019-2030)
5.2 Global Pruritus Therapeutics Growth Trends by Region
5.2.1 Global Pruritus Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Pruritus Therapeutics Historic Market Size by Region (2019-2024)
5.2.3 Pruritus Therapeutics Forecasted Market Size by Region (2025-2030)
5.3 Pruritus Therapeutics Market Dynamics
5.3.1 Pruritus Therapeutics Industry Trends
5.3.2 Pruritus Therapeutics Market Drivers
5.3.3 Pruritus Therapeutics Market Challenges
5.3.4 Pruritus Therapeutics Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Pruritus Therapeutics Players by Revenue
6.1.1 Global Top Pruritus Therapeutics Players by Revenue (2019-2024)
6.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
6.2 Global Pruritus Therapeutics Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Pruritus Therapeutics Head office and Area Served
6.4 Global Pruritus Therapeutics Players, Product Type & Application
6.5 Global Pruritus Therapeutics Players, Date of Enter into This Industry
6.6 Global Pruritus Therapeutics Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Pruritus Therapeutics Market Size (2019-2030)
7.2 North America Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Pruritus Therapeutics Market Size by Country (2019-2024)
7.4 North America Pruritus Therapeutics Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Pruritus Therapeutics Market Size (2019-2030)
8.2 Europe Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Pruritus Therapeutics Market Size by Country (2019-2024)
8.4 Europe Pruritus Therapeutics Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Pruritus Therapeutics Market Size (2019-2030)
9.2 Asia-Pacific Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Pruritus Therapeutics Market Size by Country (2019-2024)
9.4 Asia-Pacific Pruritus Therapeutics Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Pruritus Therapeutics Market Size (2019-2030)
10.2 Latin America Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Pruritus Therapeutics Market Size by Country (2019-2024)
10.4 Latin America Pruritus Therapeutics Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pruritus Therapeutics Market Size (2019-2030)
11.2 Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Pruritus Therapeutics Market Size by Country (2019-2024)
11.4 Middle East & Africa Pruritus Therapeutics Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 J&J
12.1.1 J&J Company Information
12.1.2 J&J Business Overview
12.1.3 J&J Revenue in Pruritus Therapeutics Business (2019-2024)
12.1.4 J&J Pruritus Therapeutics Product Portfolio
12.1.5 J&J Recent Developments
12.2 Abbott
12.2.1 Abbott Company Information
12.2.2 Abbott Business Overview
12.2.3 Abbott Revenue in Pruritus Therapeutics Business (2019-2024)
12.2.4 Abbott Pruritus Therapeutics Product Portfolio
12.2.5 Abbott Recent Developments
12.3 Amgen
12.3.1 Amgen Company Information
12.3.2 Amgen Business Overview
12.3.3 Amgen Revenue in Pruritus Therapeutics Business (2019-2024)
12.3.4 Amgen Pruritus Therapeutics Product Portfolio
12.3.5 Amgen Recent Developments
12.4 LEO Pharma
12.4.1 LEO Pharma Company Information
12.4.2 LEO Pharma Business Overview
12.4.3 LEO Pharma Revenue in Pruritus Therapeutics Business (2019-2024)
12.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
12.4.5 LEO Pharma Recent Developments
12.5 Novartis
12.5.1 Novartis Company Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Revenue in Pruritus Therapeutics Business (2019-2024)
12.5.4 Novartis Pruritus Therapeutics Product Portfolio
12.5.5 Novartis Recent Developments
12.6 Bayer
12.6.1 Bayer Company Information
12.6.2 Bayer Business Overview
12.6.3 Bayer Revenue in Pruritus Therapeutics Business (2019-2024)
12.6.4 Bayer Pruritus Therapeutics Product Portfolio
12.6.5 Bayer Recent Developments
12.7 Pfizer
12.7.1 Pfizer Company Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Revenue in Pruritus Therapeutics Business (2019-2024)
12.7.4 Pfizer Pruritus Therapeutics Product Portfolio
12.7.5 Pfizer Recent Developments
12.8 UCB Pharma
12.8.1 UCB Pharma Company Information
12.8.2 UCB Pharma Business Overview
12.8.3 UCB Pharma Revenue in Pruritus Therapeutics Business (2019-2024)
12.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
12.8.5 UCB Pharma Recent Developments
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Information
12.9.2 GlaxoSmithKline Business Overview
12.9.3 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2019-2024)
12.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
12.9.5 GlaxoSmithKline Recent Developments
12.10 Galderma
12.10.1 Galderma Company Information
12.10.2 Galderma Business Overview
12.10.3 Galderma Revenue in Pruritus Therapeutics Business (2019-2024)
12.10.4 Galderma Pruritus Therapeutics Product Portfolio
12.10.5 Galderma Recent Developments
12.11 Huapont
12.11.1 Huapont Company Information
12.11.2 Huapont Business Overview
12.11.3 Huapont Revenue in Pruritus Therapeutics Business (2019-2024)
12.11.4 Huapont Pruritus Therapeutics Product Portfolio
12.11.5 Huapont Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pruritus Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Pruritus Therapeutics Revenue Market Share by Type (2018-2023)
Table 7. Global Pruritus Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Pruritus Therapeutics Revenue Market Share by Type (2024-2029)
Table 9. Global Pruritus Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Pruritus Therapeutics Revenue Market Share by Application (2018-2023)
Table 11. Global Pruritus Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Pruritus Therapeutics Revenue Market Share by Application (2024-2029)
Table 13. Global Pruritus Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Pruritus Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Pruritus Therapeutics Market Share by Region (2018-2023)
Table 16. Global Pruritus Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Pruritus Therapeutics Market Share by Region (2024-2029)
Table 18. Pruritus Therapeutics Market Trends
Table 19. Pruritus Therapeutics Market Drivers
Table 20. Pruritus Therapeutics Market Challenges
Table 21. Pruritus Therapeutics Market Restraints
Table 22. Global Top Pruritus Therapeutics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Pruritus Therapeutics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Pruritus Therapeutics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Pruritus Therapeutics, Headquarters and Area Served
Table 26. Global Pruritus Therapeutics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pruritus Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. J&J Company Detail
Table 46. J&J Business Overview
Table 47. J&J Pruritus Therapeutics Product
Table 48. J&J Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 49. J&J Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Pruritus Therapeutics Product
Table 53. Abbott Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Amgen Company Detail
Table 56. Amgen Business Overview
Table 57. Amgen Pruritus Therapeutics Product
Table 58. Amgen Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Amgen Recent Development
Table 60. LEO Pharma Company Detail
Table 61. LEO Pharma Business Overview
Table 62. LEO Pharma Pruritus Therapeutics Product
Table 63. LEO Pharma Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 64. LEO Pharma Recent Development
Table 65. Novartis Company Detail
Table 66. Novartis Business Overview
Table 67. Novartis Pruritus Therapeutics Product
Table 68. Novartis Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Bayer Company Detail
Table 71. Bayer Business Overview
Table 72. Bayer Pruritus Therapeutics Product
Table 73. Bayer Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Pruritus Therapeutics Product
Table 78. Pfizer Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. UCB Pharma Company Detail
Table 81. UCB Pharma Business Overview
Table 82. UCB Pharma Pruritus Therapeutics Product
Table 83. UCB Pharma Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 84. UCB Pharma Recent Development
Table 85. GlaxoSmithKline Company Detail
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Pruritus Therapeutics Product
Table 88. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. Galderma Company Detail
Table 91. Galderma Business Overview
Table 92. Galderma Pruritus Therapeutics Product
Table 93. Galderma Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Galderma Recent Development
Table 95. Huapont Company Detail
Table 96. Huapont Business Overview
Table 97. Huapont Pruritus TherapeuticsProduct
Table 98. Huapont Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Huapont Recent Development
Table 100. J&J Company Information
Table 101. J&J Business Overview
Table 102. J&J Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 103. J&J Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 104. J&J Recent Development
Table 105. Abbott Company Information
Table 106. Abbott Business Overview
Table 107. Abbott Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Abbott Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 109. Abbott Recent Development
Table 110. Amgen Company Information
Table 111. Amgen Business Overview
Table 112. Amgen Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 113. Amgen Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 114. Amgen Recent Development
Table 115. LEO Pharma Company Information
Table 116. LEO Pharma Business Overview
Table 117. LEO Pharma Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 118. LEO Pharma Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 119. LEO Pharma Recent Development
Table 120. Novartis Company Information
Table 121. Novartis Business Overview
Table 122. Novartis Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 123. Novartis Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 124. Novartis Recent Development
Table 125. Bayer Company Information
Table 126. Bayer Business Overview
Table 127. Bayer Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Bayer Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bayer Recent Development
Table 130. Pfizer Company Information
Table 131. Pfizer Business Overview
Table 132. Pfizer Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Pfizer Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Pfizer Recent Development
Table 135. UCB Pharma Company Information
Table 136. UCB Pharma Business Overview
Table 137. UCB Pharma Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 138. UCB Pharma Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 139. UCB Pharma Recent Development
Table 140. GlaxoSmithKline Company Information
Table 141. GlaxoSmithKline Business Overview
Table 142. GlaxoSmithKline Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 143. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 144. GlaxoSmithKline Recent Development
Table 145. Galderma Company Information
Table 146. Galderma Business Overview
Table 147. Galderma Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 148. Galderma Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 149. Galderma Recent Development
Table 150. Huapont Company Information
Table 151. Huapont Business Overview
Table 152. Huapont Pruritus TherapeuticsRevenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 153. Huapont Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 154. Huapont Recent Development
Table 155. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pruritus Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Pruritus Therapeutics Revenue Market Share by Type (2018-2023)
Table 7. Global Pruritus Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Pruritus Therapeutics Revenue Market Share by Type (2024-2029)
Table 9. Global Pruritus Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Pruritus Therapeutics Revenue Market Share by Application (2018-2023)
Table 11. Global Pruritus Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Pruritus Therapeutics Revenue Market Share by Application (2024-2029)
Table 13. Global Pruritus Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Pruritus Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Pruritus Therapeutics Market Share by Region (2018-2023)
Table 16. Global Pruritus Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Pruritus Therapeutics Market Share by Region (2024-2029)
Table 18. Pruritus Therapeutics Market Trends
Table 19. Pruritus Therapeutics Market Drivers
Table 20. Pruritus Therapeutics Market Challenges
Table 21. Pruritus Therapeutics Market Restraints
Table 22. Global Top Pruritus Therapeutics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Pruritus Therapeutics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Pruritus Therapeutics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Pruritus Therapeutics, Headquarters and Area Served
Table 26. Global Pruritus Therapeutics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pruritus Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Pruritus Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Pruritus Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. J&J Company Detail
Table 46. J&J Business Overview
Table 47. J&J Pruritus Therapeutics Product
Table 48. J&J Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 49. J&J Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Pruritus Therapeutics Product
Table 53. Abbott Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Amgen Company Detail
Table 56. Amgen Business Overview
Table 57. Amgen Pruritus Therapeutics Product
Table 58. Amgen Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Amgen Recent Development
Table 60. LEO Pharma Company Detail
Table 61. LEO Pharma Business Overview
Table 62. LEO Pharma Pruritus Therapeutics Product
Table 63. LEO Pharma Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 64. LEO Pharma Recent Development
Table 65. Novartis Company Detail
Table 66. Novartis Business Overview
Table 67. Novartis Pruritus Therapeutics Product
Table 68. Novartis Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Bayer Company Detail
Table 71. Bayer Business Overview
Table 72. Bayer Pruritus Therapeutics Product
Table 73. Bayer Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Bayer Recent Development
Table 75. Pfizer Company Detail
Table 76. Pfizer Business Overview
Table 77. Pfizer Pruritus Therapeutics Product
Table 78. Pfizer Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Pfizer Recent Development
Table 80. UCB Pharma Company Detail
Table 81. UCB Pharma Business Overview
Table 82. UCB Pharma Pruritus Therapeutics Product
Table 83. UCB Pharma Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 84. UCB Pharma Recent Development
Table 85. GlaxoSmithKline Company Detail
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Pruritus Therapeutics Product
Table 88. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 89. GlaxoSmithKline Recent Development
Table 90. Galderma Company Detail
Table 91. Galderma Business Overview
Table 92. Galderma Pruritus Therapeutics Product
Table 93. Galderma Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Galderma Recent Development
Table 95. Huapont Company Detail
Table 96. Huapont Business Overview
Table 97. Huapont Pruritus TherapeuticsProduct
Table 98. Huapont Revenue in Pruritus Therapeutics Business (2017-2022) & (US$ Million)
Table 99. Huapont Recent Development
Table 100. J&J Company Information
Table 101. J&J Business Overview
Table 102. J&J Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 103. J&J Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 104. J&J Recent Development
Table 105. Abbott Company Information
Table 106. Abbott Business Overview
Table 107. Abbott Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 108. Abbott Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 109. Abbott Recent Development
Table 110. Amgen Company Information
Table 111. Amgen Business Overview
Table 112. Amgen Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 113. Amgen Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 114. Amgen Recent Development
Table 115. LEO Pharma Company Information
Table 116. LEO Pharma Business Overview
Table 117. LEO Pharma Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 118. LEO Pharma Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 119. LEO Pharma Recent Development
Table 120. Novartis Company Information
Table 121. Novartis Business Overview
Table 122. Novartis Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 123. Novartis Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 124. Novartis Recent Development
Table 125. Bayer Company Information
Table 126. Bayer Business Overview
Table 127. Bayer Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 128. Bayer Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 129. Bayer Recent Development
Table 130. Pfizer Company Information
Table 131. Pfizer Business Overview
Table 132. Pfizer Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Pfizer Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Pfizer Recent Development
Table 135. UCB Pharma Company Information
Table 136. UCB Pharma Business Overview
Table 137. UCB Pharma Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 138. UCB Pharma Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 139. UCB Pharma Recent Development
Table 140. GlaxoSmithKline Company Information
Table 141. GlaxoSmithKline Business Overview
Table 142. GlaxoSmithKline Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 143. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 144. GlaxoSmithKline Recent Development
Table 145. Galderma Company Information
Table 146. Galderma Business Overview
Table 147. Galderma Pruritus Therapeutics Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 148. Galderma Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 149. Galderma Recent Development
Table 150. Huapont Company Information
Table 151. Huapont Business Overview
Table 152. Huapont Pruritus TherapeuticsRevenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million)
Table 153. Huapont Revenue in Pruritus Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 154. Huapont Recent Development
Table 155. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pruritus Therapeutics Product Picture
Figure 5. Global Pruritus Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Pruritus Therapeutics Market Share by Type: 2022 VS 2029
Figure 7. Antihistamines Product Picture
Figure 8. Corticosteroids Product Picture
Figure 9. Calcineurin Inhibitors Product Picture
Figure 10. Others Product Picture
Figure 11. Global Pruritus Therapeutics Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Pruritus Therapeutics Market Share by Application: 2022 VS 2029
Figure 13. External Use Product Picture
Figure 14. Oral Product Picture
Figure 15. Injection Product Picture
Figure 16. Global Pruritus Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Pruritus Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Pruritus Therapeutics Market Share by Region: 2022 VS 2029
Figure 19. Global Pruritus Therapeutics Market Share by Players in 2022
Figure 20. Global Pruritus Therapeutics Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 25. United States Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 29. Germany Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 37. China Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 45. Mexico Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 49. Turkey Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. J&J Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 54. Amgen Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 55. LEO Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 57. Bayer Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 59. UCB Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 61. Galderma Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 62. Huapont Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pruritus Therapeutics Product Picture
Figure 5. Global Pruritus Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Pruritus Therapeutics Market Share by Type: 2022 VS 2029
Figure 7. Antihistamines Product Picture
Figure 8. Corticosteroids Product Picture
Figure 9. Calcineurin Inhibitors Product Picture
Figure 10. Others Product Picture
Figure 11. Global Pruritus Therapeutics Market Size by Application (2023-2029) & (US$ Million)
Figure 12. Global Pruritus Therapeutics Market Share by Application: 2022 VS 2029
Figure 13. External Use Product Picture
Figure 14. Oral Product Picture
Figure 15. Injection Product Picture
Figure 16. Global Pruritus Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Pruritus Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Pruritus Therapeutics Market Share by Region: 2022 VS 2029
Figure 19. Global Pruritus Therapeutics Market Share by Players in 2022
Figure 20. Global Pruritus Therapeutics Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 25. United States Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 29. Germany Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 37. China Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 45. Mexico Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Pruritus Therapeutics Market Share by Country (2018-2029)
Figure 49. Turkey Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Pruritus Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. J&J Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 54. Amgen Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 55. LEO Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 57. Bayer Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 58. Pfizer Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 59. UCB Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 61. Galderma Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
Figure 62. Huapont Revenue Growth Rate in Pruritus Therapeutics Business (2018-2023)
